Phenylacetate is an Inhibitor of Prostatic Growth and Development in Organ Culture
Author:
Affiliation:
1. Department of Medicine, Nephrology Division, the Department of Anatomy and Center for Reproductive Sciences, University of California, San Francisco, California, and the Cancer Center, University of Virginia, Charlottesville, Charlottesville.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference54 articles.
1. Phenylacetic acid in human body fluids: high correlation between plasma and cerebrospinal fluid concentration values;Sandler;J. Neurol. Neurosurg. Psychol,1982
2. The conjugation of phenylacetic acid in man, sub-human primates, and some non-primate species;James;Proc. R. Soc. Lond. B. Biol. Sci,1972
3. Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis;Brusilow;N. Engl. J. Med,1984
4. Phenylacetylglutamine may replace urea as a vehicle for waste nitrogen excretion;Brusilow;Pediatr. Res,1991
5. A new therapy for portal systemic encephalopathy;Mendenhall;Am. J. Gastroenterol,1986
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Morphometric Analysis of Rat Prostate Development: Roles of MEK/ERK and Rho Signaling Pathways in Prostatic Morphogenesis;Biomolecules;2021-12-04
2. VEGF inhibitor (Iressa) arrests histone deacetylase expression: Single-cell cotransfection imaging cytometry for multi-target-multi-drug analysis;Journal of Cellular Physiology;2011-04-25
3. Regulation of Epithelial Branching Morphogenesis and Cancer Cell Growth of the Prostate by Wnt Signaling;PLoS ONE;2008-05-14
4. Growth inhibition of MCF-7 tumor cell line by phenylacetate linked to functionalized dextran;Journal of Biomaterials Science, Polymer Edition;2004-01
5. Growth inhibition of human melanoma tumor cells by the combination of sodium phenylacetate (NaPA) and substituted dextrans and one NaPA–dextran conjugate;Anti-Cancer Drugs;2002-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3